Omnicell (NSDQ:OMCL) and Fresenius Kabi announced today that they are collaborating on new technology for managing controlled substances. The collaboration aims to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing controlled substances in patient care areas. Get the full story at our sister site, Drug Delivery Business […]
Omnicell Inc.
Biolase CEO Flynn steps down | Personnel Moves – April 13, 2018
Biolase (NSDQ:BIOL) said this week its CEO Harold Flynn has resigned from the company to pursue other interests, and that current CFO John Beaver will step in to act as interim CEO. The transition will be made immediately, the Irvine, Calif.-based company said. “I would like to thank Harold for the leadership and commitment he has […]
Medtronic taps Harvard cardiologist Mauri for clinical research VP | Personnel Moves – April 10, 2018
Medtronic (NYSE:MDT) said last week it tapped Harvard Medical School professor and cardiologist Dr. Laura Mauri as its new vice president of global clinical research and analytics. In the new position, Dr. Mauri will direct dynamic global clinical research strategies as well as the development of novel analytical and data science solutions as the Fridley, Minn.-baesd […]
Omnicell shares surge after Q2 beat
Shares in Omnicell (NSDQ:OMCL) soared today after the company beat expectations on Wall Street with its second quarter results. The Mountain View, Calif.-based company posted profits of $837,000, or 2¢ per share, on sales of $180.9 million for the 3 months ended June 30, for sales growth of 4.6% compared with the same period last year. Get […]
Baxter releases infusion pump programming software
Baxter (NYSE:BAX) launched its Sigma Spectrum Safety Management System this week at the American Society of Health-System Pharmacists meeting. The infusion pump system consists of an analytics software and a suite of remote professional services for cyber-security monitoring. The Deerfield, Ill.-based company said its Sigma Spectrum system was developed to minimize infusion pump programming risks, […]
B Braun announces collab deal with Omnicell
B. Braun said this week it inked a collaborative deal with Omnicell to help decrease the time and clinical support necessary to manage IV infusions and IV compounding. Through the deal, Omnicell will be able to use B. Braun’s DoseTrac infusion management software through a hyperlink in Omnicell’s performance center, the companies said. Get the […]
Haemonetics breaks annual sales record, Q4 profits up five fold | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Earnings roundup: Thoratec profits leap 58 percent
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Omnicell’s Q4 net plunges 83 percent
Omnicell Inc. (NSDQ:OMCL) posted fourth-quarter sales of $42.9 million for the three months ended Dec. 31, 2009, down 16.3 percent compared with $51.3 million during the same period in 2008. Net income plunged 83.2 percent to $557,000, compared with $3.3 million during Q4 2008:
